Sunset Begins For Roche's Herceptin As Amgen/Allergan Biosimilar Launches

 
• By Jessica Merrill

Amgen and Allergan launched the first US biosimilar for Roche's Herceptin – and the Swiss pharma's Avastin – at a 15% discount to the brand-name products' list prices. Infographic reviews Herceptin's past and its future competitors.

sunset
The sun may set for Roche's Herceptin sales as US biosimilars launch. • Source: Shutterstock

More from Biosimilars

More from Biosimilars & Generics